IMPLANTABLE TEMPERATURE MEASURING MICROCHIP LAUNCHED BY POSITIVE ID

Microchip Will Integrate With PositiveID‘s Wireless Body(TM) Platform to Provide Early Warning at the Onset of an Illness

PositiveID Corporation (“PositiveID” or the “Company“) (Nasdaq:PSID) announced today that it has completed the development of its temperature-sensing microchip in conjunction with development partner RFID Solutions of Malaga, Spain. The microchip, which uses radio frequency identification (RFID) technology, is able to measure internal temperature within the body and communicate that temperature wirelessly to an external reader. The Company plans to integrate the temperature-sensing microchip with its Wireless Body™ platform.

As previously announced in November 2010, PositiveID teamed up with RFID Solutions, an advanced technical development group with innovative automated manufacturing and expertise in specialized requirements for sensors in RFID markets, to develop the temperature-sensing microchip for use in humans.

The Company expects its Wireless Body platform will continue to evolve with the addition of other bio-sensing capabilities, including glucose-sensing through its GlucoChip™, which is currently under development. The Wireless Body will be designed to enhance wellness and disease management, for diabetes and other chronic illnesses, by allowing healthcare systems to communicate with each other and deliver solutions to patients seamlessly.

Scott R. Silverman, Chairman and CEO of PositiveID, said, “When a person spikes a fever, it is a signal that their body is fighting an infection. By being able to continuously monitor temperature, it could provide an early warning to a caregiver at the onset of an illness. With the completion of this first bio-sensing microchip we will also explore other bio-sensing functions to integrate with the Wireless Body through our patent for an embedded bio-sensor system to improve remote patient monitoring.”

The Wireless Body communication system is built on the Company’s Patent No. 7,125,382 for an Embedded Bio-Sensor System.

About PositiveID Corporation

PositiveID Corporation develops and markets healthcare and information management products through its diagnostic devices and identification technologies, and its proprietary disease management tools. PositiveID’s implantable healthcare devices and external hardware and software products are designed to communicate wirelessly to improve healthcare and the patient’s quality of life. For more information on PositiveID, please visit www.PositiveIDCorp.com.

Enhanced by Zemanta
Related Posts Plugin for WordPress, Blogger...